Pages that link to "Q42718204"
Jump to navigation
Jump to search
The following pages link to Richard Slayden (Q42718204):
Displaying 50 items.
- Mycobacterium tuberculosis septum site determining protein, Ssd encoded by rv3660c, promotes filamentation and elicits an alternative metabolic and dormancy stress response (Q21263107) (← links)
- Implications of high level pseudogene transcription in Mycobacterium leprae (Q24645425) (← links)
- Slow-Onset Inhibition of the FabI Enoyl Reductase from Francisella tularensis : Residence Time and in Vivo Activity (Q27653711) (← links)
- Time-Dependent Diaryl Ether Inhibitors of InhA: Structure-Activity Relationship Studies of Enzyme Inhibition, Antibacterial Activity, and in vivo Efficacy (Q27682088) (← links)
- Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase Inhibitor (Q27683440) (← links)
- Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis (Q28210003) (← links)
- Mycolic acids: structure, biosynthesis and physiological functions (Q28289888) (← links)
- Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs (Q28378007) (← links)
- Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis (Q28486766) (← links)
- Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins (Q28487171) (← links)
- Morphological features and signature gene response elicited by inactivation of FtsI in Mycobacterium tuberculosis (Q28487277) (← links)
- The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis (Q28487416) (← links)
- A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927 (Q28487455) (← links)
- A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis (Q28537897) (← links)
- Immune Modulation as an Effective Adjunct Post-exposure Therapeutic for B. pseudomallei (Q28553046) (← links)
- Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids. (Q30843747) (← links)
- Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitors (Q33292548) (← links)
- Discovery, synthesis, and biological evaluation of piperidinol analogs with anti-tuberculosis activity (Q33433802) (← links)
- Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents. (Q33711825) (← links)
- Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents (Q33761632) (← links)
- In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis (Q33797084) (← links)
- The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis. (Q33960385) (← links)
- Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensis (Q34543138) (← links)
- Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei (Q34566539) (← links)
- Isothermal amplification and molecular typing of the obligate intracellular pathogen Mycobacterium leprae isolated from tissues of unknown origins (Q34569161) (← links)
- Discovery of anti-TB agents that target the cell-division protein FtsZ. (Q34576179) (← links)
- A specific interaction of small molecule entry inhibitors with the envelope glycoprotein complex of the Junín hemorrhagic fever arenavirus (Q34675921) (← links)
- Benzimidazole-based antibacterial agents against Francisella tularensis (Q34691423) (← links)
- MazF6 toxin of Mycobacterium tuberculosis demonstrates antitoxin specificity and is coupled to regulation of cell growth by a Soj-like protein (Q35028889) (← links)
- Iterative feature removal yields highly discriminative pathways (Q35052449) (← links)
- Substituted diphenyl ethers as a novel chemotherapeutic platform against Burkholderia pseudomallei (Q35079030) (← links)
- Use of protein microarrays to define the humoral immune response in leprosy patients and identification of disease-state-specific antigenic profiles (Q35217520) (← links)
- Adeno-associated virus gene therapy vector scAAVIGF-I for transduction of equine articular chondrocytes and RNA-seq analysis (Q35878903) (← links)
- Identification of the apparent carrier in mycolic acid synthesis (Q36000971) (← links)
- Synthesis and evaluation of new 2-aminothiophenes against Mycobacterium tuberculosis (Q36037140) (← links)
- Anomaly Detection in Host Signaling Pathways for the Early Prognosis of Acute Infection (Q36105651) (← links)
- Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model (Q36185304) (← links)
- Transient In Vivo Resistance Mechanisms of Burkholderia pseudomallei to Ceftazidime and Molecular Markers for Monitoring Treatment Response (Q36247396) (← links)
- The Francisella tularensis FabI enoyl-acyl carrier protein reductase gene is essential to bacterial viability and is expressed during infection (Q36558861) (← links)
- Menaquinone synthesis is critical for maintaining mycobacterial viability during exponential growth and recovery from non-replicating persistence (Q36561241) (← links)
- Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis (Q36754701) (← links)
- FtsZ: a novel target for tuberculosis drug discovery (Q36754709) (← links)
- Synthesis and in vitro antimycobacterial activity of B-ring modified diaryl ether InhA inhibitors (Q36800124) (← links)
- Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents (Q36857437) (← links)
- Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity (Q37030173) (← links)
- Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease. (Q37139651) (← links)
- Substituted diphenyl ethers as a broad-spectrum platform for the development of chemotherapeutics for the treatment of tularaemia (Q37383936) (← links)
- The Burkholderia pseudomallei enoyl-acyl carrier protein reductase FabI1 is essential for in vivo growth and is the target of a novel chemotherapeutic with efficacy (Q37544698) (← links)
- SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents (Q37600601) (← links)
- Updating and curating metabolic pathways of TB. (Q38078612) (← links)